🇩🇪 EVT.DE — Evotec SE

Salud Mantener
← Volver

Precio actual

3,0920 EUR

Máx. histórico

91,9533

9744 días

Split 2:1 del 18/08/2000

Caída desde máximo

-96,64%

Rango 52 semanas

2,4060 – 6,7300

Variación hoy

+7,14%

Cierre anterior

2,8860

Rango de hoy

2,9380 – 3,1680

Volumen hoy

2.443.451

Peor caída histórica

-99,40%

02/03/2000 → 02/03/2009

Aún sin recuperar

Volatilidad anualizada ⓘ

59,98%

Información
Nombre completo
Evotec SE
Divisa
EUR
Mercado
XETRA
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
4.461
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
4,4429 EUR (puede no estar actualizado)
Primera cotización
12/11/1999
Precio actualizado
hace 6 horas
Sobre la empresa

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just – Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic diseases, and rare diseases. It is also developingcentral nervous system (CNS) and cardiometabolic diseases; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. In addition, it has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB. Further, the company serves pharma and biotechnology companies, academic institutions, patient advocacy groups, and venture capital. Evotec SE has strategic collaboration with Almirall, S.A. for the development of novel therapeutics for severe skin diseases, including a range of immune-mediated inflammatory conditions. The company collaborate with Odyssey Therapeutics, Inc. to designs and develops AI based discovery platform to discover new treatments in autoimmune and inflammatory diseases. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Splits Registrados en el histórico de precios
Fecha Ratio
18/08/2000 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/03/2023 17,4600 17,4800 17,1550 17,2850 -1,68% 1,86% 302.322
08/03/2023 17,6250 17,8500 17,3700 17,5800 -1,04% 2,72% 221.262
07/03/2023 17,5000 18,2600 17,5000 17,7650 +0,97% 4,34% 610.734
06/03/2023 17,4900 17,6100 17,2100 17,5950 +2,03% 2,29% 258.260
03/03/2023 16,7800 17,2550 16,7800 17,2450 +3,45% 2,83% 210.212
02/03/2023 16,4800 16,8000 16,2950 16,6700 +0,36% 3,06% 247.363
01/03/2023 17,1250 17,1850 16,5800 16,6100 -2,32% 3,53% 483.411
28/02/2023 17,8300 17,8300 16,9400 17,0050 -4,81% 4,99% 564.595
27/02/2023 17,7000 17,9500 17,6800 17,8650 +1,07% 1,53% 228.557
24/02/2023 18,4150 18,4800 17,6400 17,6750 -3,60% 4,56% 504.964
23/02/2023 18,4000 18,5900 18,2750 18,3350 +0,36% 1,71% 205.668
22/02/2023 18,4100 18,4100 18,0000 18,2700 -1,08% 2,23% 301.247
21/02/2023 18,7950 18,8950 18,4200 18,4700 -2,40% 2,53% 272.915
20/02/2023 18,5950 19,0600 18,5950 18,9250 +2,49% 2,50% 313.140
17/02/2023 18,3400 18,5800 18,2850 18,4650 -0,40% 1,61% 284.316
16/02/2023 18,7300 18,8000 18,4650 18,5400 +0,11% 1,79% 250.955
15/02/2023 18,5050 18,6300 18,3900 18,5200 -0,05% 1,30% 183.382
14/02/2023 18,6150 18,7350 18,3000 18,5300 -0,19% 2,34% 360.632
13/02/2023 18,3500 18,6150 18,0550 18,5650 +0,98% 3,05% 306.639
10/02/2023 18,7000 18,8700 18,2800 18,3850 -2,08% 3,16% 308.987
09/02/2023 18,9650 19,1100 18,7250 18,7750 -0,58% 2,03% 310.083
08/02/2023 18,7300 19,1650 18,6900 18,8850 +1,78% 2,54% 318.580
07/02/2023 18,7750 18,8400 18,2750 18,5550 -1,28% 3,01% 391.881
06/02/2023 18,7800 18,8800 18,4750 18,7950 -1,05% 2,16% 298.451
03/02/2023 19,2400 19,6400 18,6950 18,9950 -1,94% 4,91% 630.753
02/02/2023 18,3750 19,3700 18,3750 19,3700 +8,36% 5,41% 718.984
01/02/2023 18,0850 18,2550 17,8750 17,8750 -0,64% 2,10% 351.216
31/01/2023 18,2050 18,2200 17,8800 17,9900 -1,72% 1,87% 343.313
30/01/2023 18,7750 18,9650 18,2700 18,3050 -2,68% 3,70% 388.172
27/01/2023 18,9200 18,9400 18,6000 18,8100 -0,56% 1,80% 390.707